Table 1.
Cancer | Sample | Function | Pathway | Reference(s) |
---|---|---|---|---|
Gastric cancer | Tissue | Promotes invasion and migration and inhibits apoptosis | MAPK–Akt | 14 |
Gallbladder cancer | Tissue | Increases drug sensitivity | – | 17, 12 |
Glioblastoma | Tissue | Regulator of glioblastoma growth | – | 18 |
Pancreatic cancer | Tissue | Putative oncogene | – | 9 |
Sarcoma | Tissue | Receptor oncotargets | ERK | 23 |
Colon cancer | Cells | Metastasis | – | 11 |
Breast cancer | Cells | Migrates or invades | – | 15 |
Ovarian cancer | Serum | Serological tumorigenesis biomarkers | – | 13, 19, 22 |
Colorectal cancer | Cells | Migration and invasion | RVD | 24 |
Endometrioid endometrial cancer | Tissue | Chemoresistance | – | 21 |
Laryngeal cancer | Cells | Promotion of ROS production | ROS | 10 |
Nasopharyngeal carcinoma | Tissue/plasma | Plasma tumor marker | – | 8 |
Gallbladder cancer | Cells | Metastasis | – | 20 |
Hepatocellular carcinoma | Cells | New targets for drug development | – | 16 |
Abbreviations: RVD, regulatory volume decrease; ROS, reactive oxygen species.